Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze KNSA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate KNSA investment potential.

What is KNSA stock price today?

Get real-time KNSA stock price, historical data, and price charts on Financhill. Track KNSA performance with our advanced analysis tools.

Is KNSA a good investment?

Evaluate KNSA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy KNSA stock?

To buy KNSA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of KNSA?

View detailed market capitalization data and company valuation metrics for KNSA on our comprehensive analysis page.

What is the P/E ratio of KNSA?

Use our fundamental analysis tools to view KNSA P/E ratio and compare valuation metrics with industry peers.

What are KNSA earnings?

View KNSA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Kiniksa Pharmaceuticals International Plc 10K Form

Buy

KNSA
Kiniksa Pharmaceuticals International Plc

Last Price:

$41.08

Seasonality Move:

7.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KNSA News And Ratings

See the #1 stock for the next 7 days that we like better than KNSA

KNSA Financial Statistics

Sales & Book Value

Annual Sales:	$423.2M
Cash Flow:	$33M
Price / Cash Flow:	30.87
Annual Sales:	$7.10
Price / Book:	5.8

Profitability

EPS (TTM):	0.44830
Net Income (TTM):	$35.9M
Gross Margin:	$233.6M
Return on Equity:	7.6%
Return on Assets:	5.78%

Kiniksa Pharmaceuticals International Plc Earnings Forecast

Key Kiniksa Pharmaceuticals International Plc Financial Ratios

The Gross Profit Margin over the past 9 years for KNSA is 55.19%.
The Selling, General & Administrative Expenses for KNSA have been equal to 39.70% of Gross Profit Margin.
The Research & Development expenses have been 26.27% of Revenue.
The Net Earning history of KNSA is -10.21% of Total Revenues.
Per Share Earnings over the last 9 years have been positive in 3 years.

Kiniksa Pharmaceuticals International Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	KNSA
CUSIP:	G5269C
Website:	kiniksa.com

Debt

Debt-to-Equity Ratio:	0.02
Current Ratio:	3.85
Quick Ratio:	3.27

Price-to-Earnings

Trailing P/E Ratio:	98.63
Forward P/E Ratio:	21.19

KNSA Technical Analysis vs Fundamental Analysis

Buy

Kiniksa Pharmaceuticals International Plc (KNSA) is a Buy

Is Kiniksa Pharmaceuticals International Plc a Buy or a Sell?

Kiniksa Pharmaceuticals International Plc stock is rated a Buy

The current Kiniksa Pharmaceuticals International Plc [KNSA] share price is $40.99. The Score for KNSA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.